Neurotoxicity and Neuroprotection
September 2009 – Vol 11 – No. 3
State of the art
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression
Ronald S. Duman, PhD
Translational research
Chromatin regulation in drug addiction and depression
William Renthal, PhD; Eric J. Nestler, MD, PhD
Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia
David A. Lewis, MD
The role of astroglia in neuroprotection
Mireille Bélanger, PhD; Pierre J. Magistretti, MD; PhD
Estradiol: a hormone with diverse and contradictory neuroprotective actions
Phyllis M. Wise, PhD; Shotaro Suzuki, PhD; Candice M. Brown, PhD
Neurotoxicity of drugs of abuse – the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
Euphrosyne Gouzoulis-Mayfrank, MD; Joerg Daumann, PhD
Pharmacological aspects
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders – relation to drug treatment
Norbert Müller, MD, PhD, DipPsych
The neurotrophic and neuroprotective effects of psychotropic agents
Joshua Hunsberger, PhD
Brief report
Neuroplasticity in addictive disorders
Charles P. O’Brien, MD, PhD